Tchou et al. showed that CAFs derived from HER2+ve breast cancer prominently augmented invasive properties involving pathways concerned with migration of cancer cells, and that these cells confer more invasiveness than TNBC and ER+ve cancers [150]. The gene discussed is ERBB2; the disease is cancer.